OMNIOX INC

Pioneering oxygen-based therapies that restore health

San Francisco, United States · Founded 2015 · $5.8M raised

Employees
1–10
Founded
2015
Business Model
B2B
Website
omniox.com
Total Funding
$5.8M
Last Round
$5.8M Series DJun 2014
Rounds
4

About

Omniox is an IND-stage biotechnology company developing the H-NOX protein platform into first-in-class OMX oxygen delivery therapeutics. The company's pipeline targets diseases where tissue hypoxia drives pathology, including oncology, cardiovascular conditions, stroke, trauma, and sickle cell disease. Founded on technology from UC Berkeley, Omniox has received grants from the National Cancer Institute, National Institute of Neurological Disorders and Stroke, and the Wellcome Trust.

Summary

OMNIOX INC is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $5.8M in total across 4 rounds, most recently a $5.8M Series D round in Jun 2014. Investors include Acadia Woods Partners, Wavemaker 360 Health and Wellcome.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingDebt FinancingApr 2020

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies